Arcutis (ARQT) EVP Patrick Burnett Sells 955 Shares

What Happened
Patrick Burnett, EVP and Chief Medical Officer of Arcutis Biotherapeutics (ARQT), sold 955 shares in an open-market transaction on 2026-08-03. The weighted average sale price was $26.12, for total proceeds of approximately $24,942. The filing states the shares were sold to cover tax withholding obligations related to the vesting of restricted stock units (RSUs).

Key Details

• Transaction date: 2026-08-03; Form 4 filed: 2026-08-05.
• Transaction type/code: Open-market sale (S).
• Shares sold and price: 955 shares at a weighted average price of $26.12; individual trade prices ranged $25.72–$26.69 (per footnote).
• Total proceeds: ~$24,942.
• Reason given: tax withholding on RSU vesting (Footnote F1).
• Footnote F2: weighted-average price reported; the filer can provide a per-trade breakdown on request.
• Shares owned after the transaction: not specified in the information provided.
• Timeliness: Filed within the standard two-business-day window (timely).

Context
Sales to cover tax withholding for vested RSUs are routine administrative transactions and do not necessarily indicate an insider's view on the company’s prospects. This filing documents a tax-related sale by an executive officer rather than a discretionary investment decision.